510(k) Report

510(k) · Cleared

Cleared

Coulter 4C-EX 300 Cell Control

K100607510(k) TraditionalCleared Nov 18, 2010260-day reviewClass II21 CFR 864.8625

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Coulter, Inc. · JPK Mixture, Hematology Quality Control

Cleared on Nov 18, 2010 as substantially equivalent to K010064 (Beckman Coulter, Inc., 2001) after a 260-day review. Its family tree reaches back 1 generation to 2001.

Decided
Nov 18, 2010
Review
260 days
Class
Class II
Product code
JPK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K010064 (2001). No later device cites it as a predicate yet.

K010064 · 4C-ES Cell, Models 7547187, 7547188, 7547189, 7547190 · Beckman Coulter, Inc. · 20012000200220042006200820102012
  1. Root · 1 generation backK010064 4C-ES Cell, Models 7547187, 7547188, 7547189, 7547190Beckman Coulter, Inc. · 2001
  2. This deviceK100607 Coulter 4C-EX 300 Cell ControlBeckman Coulter, Inc. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K0100644C-ES Cell, Models 7547187, 7547188, 7547189, 7547190Beckman Coulter, Inc.2001—
0 (this device)K100607Coulter 4C-EX 300 Cell ControlBeckman Coulter, Inc.2010—
FIG. 1 — Lineage of K100607, 2001–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K0100644C-ES Cell, Models 7547187, 7547188, 7547189, 7547190
Summary page 1
…Number COULTER® 4C®~-EX 300 COULTER®4CO-ES Beckman Coulter, K010064 Cell Control Cell Control Inc. (with additional parameter, ROW-SD)…
Beckman Coulter, Inc.2001—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JPK devices

JPK Mixture, Hematology Quality Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · JPK

4in 2016

2007: 52009: 52010: 42011: 12012: 22013: 12014: 22016: 4
2007high 5 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPK

296in 2016

2007: 44 days median2009: 187 days median2010: 267 days median2016: 296 days median
2007high 296 (2016) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPK

1in 2022

2007: 12010: 22011: 32012: 12020: 12021: 22022: 1
2007high 3 (2011) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPK

2in 2023

2007: 142008: 12010: 52011: 562012: 22014: 12019: 12020: 12021: 12023: 2
2007high 56 (2011) · low 0 (2009)2025

MAUDE reports naming product code JPK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007544114
20080—01
2009518700
2010426725
20111—356
20122—12
20131—00
20142—01
20150—00
2016429600
20170—00
20180—00
20190—01
20200—11
20210—21
20220—10
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

4C®-EX 300 Cell Control is a hematology quality control material used to monitor the performance of COULTER hematology analyzers listed in the TABLE OF EXPECTED RESULTS in conjunction with specific COULTER reagents (Refer to your instrument specific instructions for use).

The assigned values and expected ranges on the TABLE OF EXPECTED RESULTS can be used to monitor instrument performance. This product can also be used to establish your own laboratory mean.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K100607: Coulter 4C-EX 300 Cell Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100607

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026